Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Adenocarcinoma; Neoplasm Metastasis; Prostatic Neoplasms Phase 2 ClinicalTrials
CONTENTS